Redirect Notice
 The previous page is sending you to http://www.businesswire.com/news/home/20150622005641/en/Idarucizumab*-reverses-anticoagulant-effect-dabigatran-minutes-patient.

 If you do not want to visit that page, you can return to the previous page.